Evidence map›Paper›PMID 37679721›Full record

ArticleBMC public health2023

Survival times of HIV/AIDS in different AIDS Diagnostic and Treatment Guidelines from 2006 to 2020 in Liuzhou, China.

Susu Ke, Quan Fang, Jianguo Lan, Nini Qiao, Xinhong Zhang, Changping Xie, Yinguang Fan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Susu Ke *Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, China.
Quan Fang *Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, China.
Jianguo LanLiuzhou Center for Disease Control and Prevention, 1 Tanzhongxi Road, Liuzhou, 545000, Guangxi Zhuang Autonomous Region, China.
Nini QiaoDepartment of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, China.
Xinhong ZhangDepartment of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, China.
Changping Xie *Liuzhou Center for Disease Control and Prevention, 1 Tanzhongxi Road, Liuzhou, 545000, Guangxi Zhuang Autonomous Region, China. ping164007@126.com.
Yinguang Fan *Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, China. fanyinguang@163.com.
Anhui Medical University · CNLiu Zhou Center for Disease Prevention and Control · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo compare the survival rates of four timing of treatment initiation for people living with HIV/AIDS provided in China in 2006, 2011, 2015, and 2018, and to investigate the factors impacting survival time.

methodsA people living with HIV/AIDS retrospective cohort study was in Liuzhou City from April 2006 to December 2020. The information was obtained from the National Comprehensive AIDS Prevention and Control Information System. Life tables and the Kaplan-Meier method were used to calculate participant survival rates and time. The univariate and multivariate Cox regression models were used to investigate the factors related to survival.

results18,543 participants were included in this study. In four periods, the 1-year survival rates were 81%, 87%, 95%, and 95%. The 2-year survival rates were 76%, 85%, 93%, and 94%. The 3-year survival rates were 73%, 84%, 92%, and 94%. Results of multivariate Cox regression showed that sex, age of HIV diagnosis, ethnicity, household registration, occupation, marital status, the timing of treatment, education level, route of HIV transmission, whether receiving antiretroviral therapy (ART), and the count of CD4

conclusionsWith the Guidelines updated from 2006 to 2020, the 1-, 2-, and 3-year survival rates of people living with HIV/AIDS in four periods tended to increase. The timing of treatment initiation of the updated edition of the AIDS Diagnostic and Treatment Guidelines (Guidelines) significantly prolonged the survival time of people living with HIV/AIDS.

Indexed as

Acquired Immunodeficiency SyndromeHIV InfectionsChinaCognitionHumansRetrospective StudiesAntiretroviral therapyCox regression modelInfluencing factorsPeople living with HIV/AIDSSurvival time

Identifiers

PMID37679721
PMCPMC10483872
OpenAlexW4386511270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.